Insider filing · KYMR
Kymera Therapeutics, Inc.
KYMR · Healthcare · 59 filings in 24 months
ticker →
Jeffrey W. Albers sold $311K of Kymera Therapeutics (KYMR)
Executed Jun 3 2025, disclosed Jun 3 2025, the same day.
Value, as filed
$311K
6,349 sh × $49.00
Executed
Jun 3 2025
the trade date, as filed
Disclosed
Jun 3 2025
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JA
Jeffrey W. Albers
Director
profile →
Jeffrey W. Albers (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in BPMC. The largest single filing was $2.4M of SYRE (23,000 sh across 3 lots, as filed), executed Aug 7.
The name
KYMRHealthcare · Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics th…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jeffrey W. Albers in KYMR
KYMRSALE
Kymera Therapeutics, Inc.
$449K5,000 sh across 2 lots
Exec Dec 8 2025
Filed Dec 8 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $296K
5,000 sh × $59.19
Exec Oct 13 2025
Filed Oct 14 2025 · 5:30 PM ET